Literature DB >> 24064506

Hyperphosphorylation results in tau dysfunction in DNA folding and protection.

Yang Lu1, Hai-Jin He, Jun Zhou, Jun-Ye Miao, Jing Lu, Ying-Ge He, Rong Pan, Yan Wei, Ying Liu, Rong-Qiao He.   

Abstract

Hyperphosphorylation of tau occurs in preclinical and clinical stages of Alzheimer's disease (AD), and hyperphosphorylated tau is the main constituent of the paired helical filaments in the brains of mild cognitive impairment and AD patients. While most of the work described so far focused on the relationship between hyperphosphorylation of tau and microtubule disassembly as well as axonal transport impairments, both phenomena ultimately leading to cell death, little work has been done to study the correlation between tau hyperphosphorylation and DNA damage. As we showed in this study, tau hyperphosphorylation and DNA damage co-occurred under formaldehyde treatment in N2a cells, indicating that phosphorylated tau (p-Tau) induced by formaldehyde may be involved in DNA impairment. After phosphorylation, the effect of tau in preventing DNA from thermal denaturation was diminished, its ability to accelerate DNA renaturation was lost, and its function in protecting DNA from reactive oxygen species (ROS) attack was impaired. Thus, p-Tau is not only associated with the disassembly of the microtubule system, but also plays a crucial role in DNA impairment. Hyperphosphorylation-mediated dysfunction of tau protein in prevention of DNA structure from damage under the attack of ROS may provide novel insights into the mechanisms underlying tauopathies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24064506     DOI: 10.3233/JAD-130602

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  22 in total

Review 1.  Genomic integrity and the ageing brain.

Authors:  Hei-man Chow; Karl Herrup
Journal:  Nat Rev Neurosci       Date:  2015-10-14       Impact factor: 34.870

2.  Retinal thinning is uniquely associated with medial temporal lobe atrophy in neurologically normal older adults.

Authors:  Kaitlin B Casaletto; Michael E Ward; Nicholas S Baker; Brianne M Bettcher; Jeffrey M Gelfand; Yaqiao Li; Robert Chen; Shubir Dutt; Bruce Miller; Joel H Kramer; Ari J Green
Journal:  Neurobiol Aging       Date:  2016-12-21       Impact factor: 4.673

Review 3.  Amyloid Precursor Protein (APP) Metabolites APP Intracellular Fragment (AICD), Aβ42, and Tau in Nuclear Roles.

Authors:  Gerhard Multhaup; Otmar Huber; Luc Buée; Marie-Christine Galas
Journal:  J Biol Chem       Date:  2015-08-21       Impact factor: 5.157

Review 4.  Molecular and cellular mechanism of okadaic acid (OKA)-induced neurotoxicity: a novel tool for Alzheimer's disease therapeutic application.

Authors:  Pradip K Kamat; Shivika Rai; Supriya Swarnkar; Rakesh Shukla; Chandishwar Nath
Journal:  Mol Neurobiol       Date:  2014-04-08       Impact factor: 5.590

Review 5.  Roles of tau protein in health and disease.

Authors:  Tong Guo; Wendy Noble; Diane P Hanger
Journal:  Acta Neuropathol       Date:  2017-04-06       Impact factor: 17.088

Review 6.  Brain Cell Type-Specific Nuclear Proteomics Is Imperative to Resolve Neurodegenerative Disease Mechanisms.

Authors:  Ruth S Nelson; Eric B Dammer; Juliet V Santiago; Nicholas T Seyfried; Srikant Rangaraju
Journal:  Front Neurosci       Date:  2022-06-16       Impact factor: 5.152

7.  Uric formaldehyde levels are negatively correlated with cognitive abilities in healthy older adults.

Authors:  Jing Yu; Tao Su; Ting Zhou; Yingge He; Jing Lu; Juan Li; Rongqiao He
Journal:  Neurosci Bull       Date:  2014-04-15       Impact factor: 5.203

8.  Icariin protects SH-SY5Y cells from formaldehyde-induced injury through suppression of Tau phosphorylation.

Authors:  Yi-Xiang Song; Jun-Ye Miao; Min Qiang; Rong-Qiao He; Xue-Mei Wang; Wei-Wei Li
Journal:  Chin J Integr Med       Date:  2015-11-20       Impact factor: 1.978

9.  Toxicant exposure and bioaccumulation: a common and potentially reversible cause of cognitive dysfunction and dementia.

Authors:  Stephen J Genuis; Kasie L Kelln
Journal:  Behav Neurol       Date:  2015-02-04       Impact factor: 3.342

10.  From blood to brain: blood cell-based biomimetic drug delivery systems.

Authors:  Yong-Jiang Li; Jun-Yong Wu; Jihua Liu; Xiaohan Qiu; Wenjie Xu; Tiantian Tang; Da-Xiong Xiang
Journal:  Drug Deliv       Date:  2021-06-18       Impact factor: 6.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.